You may qualify for this study.
You may be eligible to participate in vTv Therapeutics’ CATT1 clinical trial based on your answers. As you have consented to sharing your contact information with study staff, someone will contact you regarding the next steps.

Questions about this Study?
Email us at: studyinfo@t1dexchange.org
